Aytu Biopharma (AYTU) Raw Materials (2019 - 2026)
Aytu Biopharma's Raw Materials was $1.14 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 1.8% from $1.12 million a year earlier but down 17.3% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Raw Materials (2019 - 2026) Analysis & Trends
From fiscal Q4 2019 onward, Aytu Biopharma has reported Raw Materials for 28 quarters.
- Raw Materials shows a five-year compound annual growth rate of -12.9% (FY2021 to FY2026).
- In earlier fiscal years, Raw Materials was $1.12 million in FY2025 (+319.2%), $266,000 in FY2024 (-79.6%), $1.3 million in FY2023 (-28.3%) and $1.81 million in FY2022 (-20.1%).
- Quarterly Raw Materials has moved between $266,000 (fiscal Q4 2024) and $2.64 million (fiscal Q1 2022) over five years.
- Compared with a year earlier, Raw Materials has increased for five straight quarters, with growth averaging 63.4% over the last eight quarters.
- The best year-over-year quarter for Raw Materials over five years was fiscal Q4 2025 (growth of 319.2%); the worst was fiscal Q4 2024 (a decline of 79.6%).
- Per Business Quant data, AYTU's Raw Materials in the three fiscal quarters before Q4 2026 was $1.37 million (Q3 2026), $1.21 million (Q2 2026) and $1.37 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 537,000.00 |
| Dec 31, 2024 | 494,000.00 |
| Sep 30, 2024 | 720,000.00 |
| Jun 30, 2024 | 266,000.00 |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 1.79 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 2.43 Mn |
| Sep 30, 2021 | 2.64 Mn |
API Access
Aytu Biopharma Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();